Literature DB >> 1331474

ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.

W Linz1, G Wiemer, B A Schölkens.   

Abstract

The role of NO-formation induced by accumulated endogenous bradykinin (BK) via local ACE-inhibition with ramiprilat (RT) or by adding BK exogenously was evaluated in cultured bovine aortic endothelial cells (BAEC) and in isolated rat hearts with post-ischaemic reperfusion injuries. Furthermore we used the n-octyl-ester of ramipril (RA-octil) which was shown to have no ACE-inhibitory action. In BAEC, ACE-inhibition by RT (1 x 10(-8)-1 x 10(-6) mol/l) or addition of BK (1 x 10(-8)-1 x 10(-6) mol/l) stimulated the formation of NO and prostacyclin (PGI2) as assessed by endothelial cyclic GMP- and 6-keto-PGF1a formation. Cyclic GMP and PGI2 synthesis was completely suppressed by the NO synthase inhibitor NG-nitro-L-arginine (L-NNA, 1 x 10(-5) mol/l) and by the B2 kinin receptor antagonist HOE 140 (1 x 10(-7) mol/l). RA-octil (1 x 10(-8)-1 x 10(-4) mol/l) did not affect endothelial cyclic GMP production in BAEC. In isolated working rat hearts subjected to local ischemia with reperfusion both RT (1 x 10(-8) mol/l) and BK (1 x 10(-9) mol/l) reduced the incidence and duration of ventricular fibrillation. In parallel myocardial function (left ventricular pressure, coronary flow) and metabolism (high energy rich phosphates) were improved showing a comparable fingerprint for RT and BK. Addition of L-NNA (1 x 10(-6) mol/l) or HOE 140 (1 x 10(-9) mol/l) abolished these protective effects of RT and BK. As in the BAEC studies RA-octil was without beneficial effects on the isolated ischaemic rat heart. The findings on BAEC show that inhibition of ACE localized on the luminal side of the vascular endothelium results in increased synthesis of NO and prostacyclin by local accumulation of endothelium-derived BK. Similar mechanisms may occur in the ischaemic rat heart leading to cardioprotection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331474     DOI: 10.1016/0022-2828(92)91103-c

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.

Authors:  Keyur B Shah; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2004-12

2.  Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.

Authors:  A Cargnoni; L Comini; P Bernocchi; T Bachetti; C Ceconi; S Curello; R Ferrari
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 3.  Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.

Authors:  K Morgan
Journal:  Br Heart J       Date:  1994-09

4.  Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.

Authors:  A Vegh; J G Papp; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

Authors:  D A Wink; I Hanbauer; M C Krishna; W DeGraff; J Gamson; J B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 6.  Nitric oxide homeostasis as a target for drug additives to cardioplegia.

Authors:  B K Podesser; S Hallström
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

7.  Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.

Authors:  B Chauvin; C Richer; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Xanthine dehydrogenase/xanthine oxidase and oxidative stress.

Authors:  H Y Chung; B S Baek; S H Song; M S Kim; J I Huh; K H Shim; K W Kim; K H Lee
Journal:  Age (Omaha)       Date:  1997-07

9.  Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.

Authors:  D Lamontagne; R Nadeau; A Adam
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 10.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.